Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Bioelectronics Corp

Healthcare US BIEL

0.0004USD
0.0001(33.33%)

Last update at 2026-06-23T19:01:00Z

Day Range

0.00040.0004
LowHigh

52 Week Range

0.00010.0005
LowHigh

Fundamentals

  • Previous Close 0.0003
  • Market Cap9.88M
  • Volume11658718
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.36445M
  • Revenue TTM1.61M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.80M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.93065M -0.72281M -0.78491M - -
Minority interest - - - - -
Net income -0.93065M -0.72281M -0.78491M - -
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit 0.36M 0.47M 0.49M - -
Reconciled depreciation - - - - -
Ebit - -0.44218M -0.57193M -0.13713M -1.03278M
Ebitda -0.39269M -0.27429M -0.34345M - -
Depreciation and amortization - 0.17M 0.23M - -
Non operating income net other - - - - -
Operating income -0.39269M -0.27429M -0.34345M - -
Other operating expenses 0.89M 0.99M 1.05M - -
Interest expense 0.54M 0.45M 0.44M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.16789M -0.22848M - -
Total revenue 0.50M 0.71M 0.71M - -
Total operating expenses 0.76M 0.74M 0.83M - -
Cost of revenue 0.13M 0.25M 0.22M - -
Total other income expense net -0.53796M -0.44852M -0.44146M - -
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - -0.28982M -1.15972M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.04M 0.14M 0.25M - -
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - 0.00000M - -
Total liab 17.45M 16.62M 16.01M - -
Total stockholder equity -17.40907M -16.47842M -15.75561M - -
Deferred long term liab - - - - -
Other current liab 0.79M 0.78M 0.93M 0.58M 1.00M
Common stock 23.34M 23.34M 23.34M 24.38M 24.13M
Capital stock - - - - -
Retained earnings -40.74485M -39.81420M -39.09139M -38.30648M -38.24635M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.00787M 0.00469M 0.05M - -
Cash and equivalents - - - - -
Total current liabilities 3.96M 4.09M 3.81M 5.93M 8.84M
Current deferred revenue 0.10M 0.21M 0.25M - -
Net debt 15.52M 14.83M 14.04M - -
Short term debt 2.04M 2.30M 1.90M - -
Short long term debt - - - - -
Short long term debt total 15.53M 14.83M 14.09M - -
Other stockholder equity - 0.00000M -23.33578M -1.18986M -1.01052M
Property plant equipment - - - - -
Total current assets 0.04M 0.14M 0.25M 0.08M 0.43M
Long term investments - - - - -
Net tangible assets - - - -15.11750M -15.12209M
Short term investments - - - - -
Net receivables 0.00420M 0.10M 0.08M 0.06M 0.16M
Long term debt - - - - -
Inventory 0.03M 0.04M 0.13M 0.03M 0.15M
Accounts payable 1.03M 0.80M 0.74M 0.65M 0.73M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 23.34M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - - - -
Change to liabilities - - - -0.51107M 0.25M
Total cashflows from investing activities - - - - -
Net borrowings - - - 0.32M 0.72M
Total cash from financing activities 0.17M 0.30M 0.52M 0.21M 0.59M
Change to operating activities - - - - 0.01M
Net income -0.93065M -0.72281M -0.22697M -0.28982M -1.15972M
Change in cash 0.00319M -0.04035M 0.04M -0.10869M 0.06M
Begin period cash flow 0.00469M 0.05M 0.00093M - -
End period cash flow 0.00787M 0.00469M 0.05M - -
Total cash from operating activities -0.16415M -0.33599M -0.47860M -0.32030M -0.52804M
Issuance of capital stock - - - - -
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.00980M 0.09M -0.10134M 0.13M -0.05246M
Change to account receivables 0.09M -0.07222M -0.02085M 0.11M 0.00950M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.30M 0.52M -0.11247M -0.13169M
Change to netincome - - - 0.25M 0.42M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.23M -0.11141M -0.06467M - -
Stock based compensation - - - - -
Other non cash items 0.54M 0.50M -0.18696M - -
Free cash flow -0.16415M -0.33599M -0.47860M - -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
BIEL
Bioelectronics Corp		 0.0001 33.33% 0.0004 - - 6.14 -
ABT
Abbott Laboratories		 2.70 3.07% 90.53 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 5.31 1.74% 310.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 1.36 1.72% 80.63 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 1.27 2.86% 45.60 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

Bioelectronics Corp

4539 Metropolitan Court, Frederick, MD, United States, 21704

Key Executives

Name Title Year Born
Mr. Andrew J. Whelan Founder 1942
Ms. Kelly A. Whelan CEO, Pres, Treasurer & Exec. Director NA
Mr. Keith E. Nalepka VP of Sales & Marketing and Exec. Director 1974
John R. Martinez Sec. & VP of Engineering NA
Ms. Kelly A. Whelan CEO, President, Treasurer & Executive Director NA
Mr. Keith E. Nalepka VP of Sales & Marketing and Executive Director 1974
Mr. John R. Martinez Secretary & VP of Engineering NA
Mr. John R. Martinez Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions